These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37986666)

  • 21. Refining nanoprobes for monitoring of inflammatory bowel disease.
    Yao R; Zhu M; Guo Z; Shen J
    Acta Biomater; 2024 Mar; 177():37-49. PubMed ID: 38364928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Unraveling the Pathogenesis of Inflammatory Bowel Disease and Search for New Therapeutic Medicines].
    Hayashi S
    Yakugaku Zasshi; 2020; 140(2):123-128. PubMed ID: 32009032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal Immune Imbalance is an Alarm in the Development of IBD.
    Hu C; Liao S; Lv L; Li C; Mei Z
    Mediators Inflamm; 2023; 2023():1073984. PubMed ID: 37554552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
    Yang C; Merlin D
    Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
    Schoultz I; Keita ÅV
    Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles.
    Gardey E; Cseresnyes Z; Sobotta FH; Eberhardt J; Haziri D; Grunert PC; Kuchenbrod MT; Gruschwitz FV; Hoeppener S; Schumann M; Gaßler N; Figge MT; Stallmach A; Brendel JC
    Small; 2024 May; 20(21):e2306482. PubMed ID: 38109123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.
    Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Caprioli F; Monteleone I; Zorzi F; De Nitto D; Colantoni A; Biancone L; Pallone F; Monteleone G
    PLoS One; 2013; 8(7):e69839. PubMed ID: 23922818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heme protects intestinal mucosal barrier in DSS-induced colitis through regulating macrophage polarization in both HO-1-dependent and HO-1-independent way.
    Wu Y; Wu B; Zhang Z; Lu H; Fan C; Qi Q; Gao Y; Li H; Feng C; Zuo J; Tang W
    FASEB J; 2020 Jun; 34(6):8028-8043. PubMed ID: 32301543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
    Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM
    Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S1PR2/RhoA/ROCK1 pathway promotes inflammatory bowel disease by inducing intestinal vascular endothelial barrier damage and M1 macrophage polarization.
    Wang X; Chen S; Xiang H; Wang X; Xiao J; Zhao S; Shu Z; Ouyang J; Liang Z; Deng M; Chen X; Zhang J; Liu H; Quan Q; Gao P; Fan J; Chen AF; Lu H
    Biochem Pharmacol; 2022 Jul; 201():115077. PubMed ID: 35537530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organoid Medicine for Inflammatory Bowel Disease.
    Wakisaka Y; Sugimoto S; Sato T
    Stem Cells; 2022 Mar; 40(2):123-132. PubMed ID: 35258629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of guggulsterone against colitis are associated with the suppression of TREM-1 and modulation of macrophages.
    Che X; Park KC; Park SJ; Kang YH; Jin HA; Kim JW; Seo DH; Kim DK; Kim TI; Kim WH; Kim SW; Cheon JH
    Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G128-G139. PubMed ID: 29543509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review.
    Liu Y; Huang J; Li S; Li Z; Chen C; Qu G; Chen K; Teng Y; Ma R; Wu X; Ren J
    Biomater Sci; 2024 Feb; 12(4):837-862. PubMed ID: 38196386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease.
    Wright PB; McDonald E; Bravo-Blas A; Baer HM; Heawood A; Bain CC; Mowat AM; Clay SL; Robertson EV; Morton F; Nijjar JS; Ijaz UZ; Milling SWF; Gaya DR
    Sci Rep; 2021 Oct; 11(1):19616. PubMed ID: 34608184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients.
    Schmidt C; Lautenschlaeger C; Collnot EM; Schumann M; Bojarski C; Schulzke JD; Lehr CM; Stallmach A
    J Control Release; 2013 Jan; 165(2):139-45. PubMed ID: 23127508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease.
    Li DF; Yang MF; Xu HM; Zhu MZ; Zhang Y; Tian CM; Nie YQ; Wang JY; Liang YJ; Yao J; Wang LS
    J Mater Chem B; 2022 Aug; 10(31):5853-5872. PubMed ID: 35876136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
    Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
    Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
    Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
    Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
    Latella G; Fiocchi C; Caprili R
    J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
    Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
    World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.